Home / World Marketplace / Archive by category Global Health & Biotech (Page 7)

Archive by category Global Health & Biotech

Late-breaking iMODERN findings presented at TCT 2025 and published in the New England Journal of Medicine highlight new evidence to guide treatment choices for heart attack patients

October 29, 2025 3-Year data from the largest global trial to date using Class I, Level A iFR in heart attack patients shows treating additional stenoses in the same procedure showed no significant difference in major outcomes compared with waiting for follow-up Additional results from the ILIAS ANOCA study highlight the sustained benefits of physiology-guided [...]

Curia Releases 2024 Environmental, Social and Governance (ESG) Report

ALBANY, N.Y., Oct. 28, 2025 (Korea Bizwire) – Curia Global, Inc. (Curia), a leading contract research, development and manufacturing organization, today announced the release of its third Environmental, Social and Governance (ESG) report. This latest report highlights the company’s new “C.U.R.I.A. Way” values—curiosity, urgency, respect, integrity and accountability—and how those values are woven into its [...]

Ascom, Dräger, and B. Braun Launch Silent ICU Solution, a Milestone in Patient-Centric Critical Care

Baar, Switzerland, 28 October 2025 Ascom, in partnership with Dräger and B. Braun, announces the launch of the Silent ICU solution, introduced at the ESICM LIVES 2025 Congress in Munich. This is a major milestone in critical care innovation and marks a new era in healing environment, patient safety, and workflow efficiency for intensive care [...]

CAPHRA announces “Asia Day” event to take place at The Good Cop 2.0 Conference Highlighting Harm Reduction in Asia Pacific

MANILA, Philippines, Oct. 27, 2025 (Korea Bizwire) – The Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA) today announced Asia Day – The Good Cop 2.0, to be held on 19 November 2025, in parallel with the WHO’s COP11. Asia Day will bring together consumer advocates, public health experts, medical professionals, and policymakers to [...]

Philips introduces industry-first cath lab integration that automatically synchronizes pre-operative CT with C-arm movement, paving the way for CT-guided PCI

October 27, 2025 New integration of Philips Advanced Visualization Workspace* with the Azurion image-guided therapy platform automatically synchronizes CT images with C-arm movement, supporting workflow efficiency and additional anatomical insights in PCI procedures1 San Francisco, USA and Amsterdam, The Netherlands – At the annual Transcatheter Cardiovascular Therapeutics (TCT 2025) meeting, Royal Philips (NYSE: PHG, AEX: PHIA), a global leader [...]

Curia Invests $4 Million to Enhance Sterile API Manufacturing

ALBANY, N.Y., Oct. 27, 2025 (Korea Bizwire) – Curia Global, Inc. (Curia), a leading global research, development and manufacturing organization, today announced the completion of a $4 million investment to upgrade its two API aseptic suites in Valladolid, Spain. The investment aligns with the latest EU GMP Annex 1 standards and reinforces Curia’s longstanding commitment [...]

KFSHRC Launches the First Facility for Gene and Cell Therapy Manufacturing in Saudi Arabia

RIYADH, Saudi Arabia, Oct. 27, 2025 (Korea Bizwire) – King Faisal Specialist Hospital and Research Centre said it will open Saudi Arabia’s first facility for manufacturing genetic and cellular therapies by late 2025, a project designed to give thousands of patients access to advanced treatments at home, reduce the cost of care by an estimated [...]

New Global Coalition Launches to Address the Hidden Threat of RSV in Adults

VIENNA, Austria, Oct. 26, 2025 (Korea Bizwire) – A new global coalition, the RSV Alliance, has been launched to raise awareness about the risks of respiratory syncytial virus (RSV) infections, with a focus on aging populations and individuals with underlying health conditions. With core members including leading advocacy organizations the International Federation on Ageing (IFA) [...]

Zymeworks Presents Initial Clinical Data from the Phase 1 trial of ZW191, an Antibody-Drug Conjugate Targeting Folate Receptor-⍺ at AACR-NCI-EORTC Conference

Preliminary efficacy data, combined with a tolerable safety profile, reinforce the potential of ZW191 in patients with advanced solid tumors, including ovarian, endometrial, and non-small cell lung cancer 64% overall response rate in gynecological cancers at doses ≥6.4mg/kg Responses observed at all doses evaluated at 3.2mg/kg and above demonstrating wide therapeutic index of Zymeworks’ novel antibody-drug [...]

UFC® and Smith+Nephew announce multi-year extension of partnership

Smith+Nephew to continue as UFC’s Preferred Sports Medicine Technology Partner Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, and UFC the world’s premier mixed martial arts organization, have announced a multi-year extension of their landmark worldwide marketing partnership forged in 2024. Under the renewal, Smith+Nephew will continue as UFC’s Preferred Sports Medicine Technology Partner, a [...]